Goodrich Katherine — SEC Form 4 filings
SEC reporting owner CIK 2044770. 6 Form 4 filings on record with FilingPulse; latest filed 2026-06-29.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-11-15 to 2026-06-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 2,954 shares, $183,384 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 2,954 shares @ $62.08 ($183,384) in Tarsus Pharmaceuticals, Inc., filed 2026-06-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | Director | 6 | — | 1 leg · 2,954 sh · $183,384 | 10 |
Form 4 filings — Goodrich Katherine
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-29 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/award (A): 3,837 (derivative) @ $0 · Grant/award (A): 2,417 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale (S): 2,954 @ $62.08 | EDGAR |
| 2026-06-16 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Option exercise (M): 2,954 · Option exercise (M): 2,954 (derivative) @ $0 | EDGAR |
| 2026-01-14 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Option exercise (M): 2,233 · Option exercise (M): 2,233 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/award (A): 4,540 (derivative) @ $0 · Grant/award (A): 2,954 (derivative) @ $0 | EDGAR |
| 2024-11-15 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 6,700 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2044770 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →